Therefore, we evaluated whether the same strategy, GS activation, would be effective in seizure and hyperammonemia mouse models, as well as in a CIS-induced depression mouse model, as a potential therapeutic strategy. This evidence concerns the gene GLUL and depressive symptom measurement.